Most recently, it has been determined that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent parts as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts being a scavenger and does not activate a 2nd messe… Read More